Skip to main content
. 2021 May 26;11:573798. doi: 10.3389/fonc.2021.573798

Table 1.

Clinical Characteristics of GCT survivors.

Subject number Sex Age at diagnosis (years) Length of time since treatment (years) Types of germinoma Tumor Loci Size of GCT (largest length in cm) Presence of hydrocephalus at presentation Treatment Total RT dosage (Gy) RT field CSI + tumor boost dose (Gy)
1 M 11.7 9.3 GCT Basal ganglia 0.7 No C + RT 30.6 CSI (21.6) + TB (9)
2 M 15.1 10.9 NGGCT Basal ganglia 3.0 No C + RT 50.0 IFRT
3 M 8.8 1.2 NGGCT Pineal 1.1 Yes C + RT 46.8 CSI (30.6) + TB (16.2)
4 M 17.9 3.1 GCT Others - Bifocal 2.3 No C + RT 30.0 WVRT + TB
5 M 9.7 8.3 GCT Basal ganglia 3.0 No C + RT 50.4 WVRT + TB
6 F 10.7 5.3 NGGCT Sellar/suprasellar 3.9 No S, C + RT 54.0 CSI (36) + TB (18)
7 M 17.2 6.8 GCT Pineal 0.9 Yes C + RT 30.0 CSI (22.5) + TB (7.5)
8 F 17.5 6.5 GCT Sellar/suprasellar 3.1 No S, C + RT 36.0 WVRT + TB
9 F 15.8 3.2 NGGCT Sellar/suprasellar 2.4 No S, C + RT 54.0 CSI (36) + TB (18)
10 M 17.3 9.7 GCT Sellar/suprasellar 1.4 No C + RT 48.0 WBRT
11 M 13.8 12.2 GCT Basal ganglia 6.0 No C + RT 52.2 WBRT
12 F 7.7 7.3 NGGCT Others - Bifocal 4.2 No C + RT 45.0 CSI (24) + TB (21)
13 F 9.8 6.2 GCT Sellar/suprasellar 1.0 No C + RT 45.0 WVRT + TB
14 M 15.2 9.8 GCT Pineal 2.7 Yes C + RT 45.5 CSI (25.5) + TB (20)
15 M 10.9 6.1 GCT Pineal 2.0 Yes S, C + RT 45.0 WBRT
16 M 16.7 1.3 GCT Sellar/suprasellar 4.1 No C + RT 36.0 WBRT
17 M 17.5 2.5 NGGCT Others - Brainstem 3.3 No S, C + RT 54.0 CSI (36) + TB (18)
18 M 10.8 8.2 NGGCT Sellar/suprasellar 1.3 No S, C + RT 30.0 WVRT + TB
19 M 17.3 9.7 GCT Others - Bifocal 4.2 No C + RT 30.6 CSI (23.4) + TB (7.2)
20 M 10.9 1.8 NGGCT Basal ganglia 3.5 No C + RT 54.0 WVRT + IFRT

C, chemotherapy; S, surgery; RT, radiotherapy; GCT, germ cell tumors; CSI, cranial spinal irradiation; IFRT, involved field radiotherapy; WBRT, whole brain radiotherapy; WVRT, whole ventricular radiotherapy; TB, tumor boost.

GCT, Germ Cell Tumor; NGGCT, Nongerminomatous Germ Cell Tumor.